Patents by Inventor Stuart Sweidler

Stuart Sweidler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
    Patent number: 6972124
    Abstract: The present invention provides a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. The invention also provides methods for treating diseases caused all or in part by deficiencies in human N-acetylgalactosamine-4-sulfatase including MPS VI and methods for producing and purifying the recombinant precursor enzyme to a highly purified form.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: December 6, 2005
    Assignee: BioMarin Pharmaceuticals Inc.
    Inventors: Minmin Qin, Gary N. Zecherle, Wai-Pan Chan, Paul A. Fitzpatrick, Stuart Sweidler, John M. Henstrand, Dan J. Wendt, Lin Chen, Christopher M. Starr
  • Precursor of N-acetylgalactosamine-4-sufatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
    Publication number: 20040131605
    Abstract: The present invention provides a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. The invention also provides methods for treating diseases caused all or in part by deficiencies in human N-acetylgalactosamine-4-sulfatase including MPS VI and methods for producing and purifying the recombinant precursor enzyme to a highly purified form.
    Type: Application
    Filed: November 7, 2003
    Publication date: July 8, 2004
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Minmin Qin, Gary N. Zecherle, Wai-Pan Chan, Paul A. Fitzpatrick, Stuart Sweidler, John M. Henstrand, Dan J. Wendt, Lin Chen, Christopher M. Starr